Literature DB >> 21427179

Volumetric modulated arc therapy planning for distal oesophageal malignancies.

M A Hawkins1, J L Bedford, A P Warrington, D M Tait.   

Abstract

OBJECTIVES: Volumetric modulated arc therapy (VMAT) is a novel form of intensity-modulated radiation therapy that allows the radiation dose to be delivered in a single gantry rotation using conformal or modulated fields. The capability of VMAT to reduce heart and cord dose, while maintaining lung receiving 20 Gy <20%, was evaluated for chemoradiation for oesophageal cancer.
METHODS: An optimised forward-planned four-field arrangement was compared with inverse-planned coplanar VMAT arcs with 35 control points for 10 patients with lower gastro-oesophageal tumours prescribed 54 Gy in 30 fractions. Conformal (cARC) and intensity-modulated (VMATi) arcs were considered. Plans were assessed and compared using the planning target volume (PTV) irradiated to 95% of the prescription dose (V95), volumes of lung irradiated to 20 Gy (V20), heart irradiated to 30 Gy (V30), spinal cord maximum dose and van't Riet conformation number (CN). The monitor units per fraction and delivery time were recorded for a single representative plan.
RESULTS: VMATi provided a significant reduction in the heart V30 (31% vs 55%; p=0.02) with better CN (0.72 vs 0.65; p=0.01) than the conformal plan. The treatment delivery was 1 min 28 s for VMAT compared with 3 min 15 s.
CONCLUSION: For similar PTV coverage, VMATi delivers a lower dose to organs at risk than conformal plans in a shorter time, and this has warranted clinical implementation.

Entities:  

Mesh:

Year:  2011        PMID: 21427179      PMCID: PMC3473937          DOI: 10.1259/bjr/25428720

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  42 in total

1.  Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes.

Authors:  P Tripp; H K Malhotra; M Javle; A Shaukat; R Russo; S De Boer; M Podgorsak; H Nava; G Y Yang
Journal:  Dis Esophagus       Date:  2005       Impact factor: 3.429

2.  Considerations in treatment planning for esophageal cancer.

Authors:  Theodore S Hong; Elizabeth M Crowley; Joseph Killoran; Harvey J Mamon
Journal:  Semin Radiat Oncol       Date:  2007-01       Impact factor: 5.934

Review 3.  Conformity index: a review.

Authors:  Loïc Feuvret; Georges Noël; Jean-Jacques Mazeron; Pierre Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-01       Impact factor: 7.038

4.  Constrained segment shapes in direct-aperture optimization for step-and-shoot IMRT.

Authors:  James L Bedford; Steve Webb
Journal:  Med Phys       Date:  2006-04       Impact factor: 4.071

Review 5.  Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.

Authors:  R Wong; R Malthaner
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

6.  Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Authors:  Anurag Chandra; Thomas M Guerrero; H Helen Liu; Susan L Tucker; Zhongxing Liao; Xiaochun Wang; Hasan Murshed; Mark D Bonnen; Amit K Garg; Craig W Stevens; Joe Y Chang; Melinda D Jeter; Radhe Mohan; James D Cox; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2005-11-17       Impact factor: 6.280

7.  Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Authors:  Shu-Lian Wang; Zhongxing Liao; Helen Liu; Jaffer Ajani; Stephen Swisher; James D Cox; Ritsuko Komaki
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

8.  Automated selection of beam orientations and segmented intensity-modulated radiotherapy (IMRT) for treatment of oesophagus tumors.

Authors:  Evert Woudstra; Ben J M Heijmen; Pascal R M Storchi
Journal:  Radiother Oncol       Date:  2005-07-18       Impact factor: 6.280

Review 9.  Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.

Authors:  J Ian Geh; Simon J Bond; Søren M Bentzen; Robert Glynne-Jones
Journal:  Radiother Oncol       Date:  2006-03-20       Impact factor: 6.280

10.  Clinical applications of volumetric modulated arc therapy.

Authors:  Martha M Matuszak; Di Yan; Inga Grills; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-25       Impact factor: 7.038

View more
  12 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.

Authors:  Li Yin; Hao Wu; Jian Gong; Jian-Hao Geng; Fan Jiang; An-Hui Shi; Rong Yu; Yong-Heng Li; Shu-Kui Han; Bo Xu; Guang-Ying Zhu
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 3.  Current strategies in chemoradiation for esophageal cancer.

Authors:  Shane Lloyd; Bryan W Chang
Journal:  J Gastrointest Oncol       Date:  2014-06

4.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

5.  Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients.

Authors:  Stefania Martini; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Viviana Contu; Christian Fiandra; Riccardo Ragona; Giorgia Catalano; Maria Antonietta Satolli; Michele Camandona; Renato Romagnoli; Umberto Ricardi; Pierfrancesco Franco
Journal:  Med Oncol       Date:  2018-10-04       Impact factor: 3.064

Review 6.  Imaging strategies in the management of oesophageal cancer: what's the role of MRI?

Authors:  Peter S N van Rossum; Richard van Hillegersberg; Frederiek M Lever; Irene M Lips; Astrid L H M W van Lier; Gert J Meijer; Maarten S van Leeuwen; Marco van Vulpen; Jelle P Ruurda
Journal:  Eur Radiol       Date:  2013-02-13       Impact factor: 5.315

7.  Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.

Authors:  Yaqin Zhao; Lu Chen; Shu Zhang; Qiang Wu; Xiaoqin Jiang; Hong Zhu; Jin Wang; Zhiping Li; Yong Xu; Ying Jie Zhang; Sen Bai; Feng Xu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

8.  Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy.

Authors:  Jang-Chun Lin; Jo-Ting Tsai; Chih-Chieh Chang; Yee-Min Jen; Ming-Hsien Li; Wei-Hsiu Liu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

9.  Influence of increment of gantry angle and number of arcs on esophageal volumetric modulated arc therapy planning in Monaco planning system: A planning study.

Authors:  L Nithya; N Arunai Nambi Raj; Sasikumar Rathinamuthu; Kanika Sharma; Manish Bhushan Pandey
Journal:  J Med Phys       Date:  2014-10

10.  An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.

Authors:  Samantha Warren; Mike Partridge; Alessandra Bolsi; Anthony J Lomax; Chris Hurt; Thomas Crosby; Maria A Hawkins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-30       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.